1. Exon-disrupting deletions ofNRXN1in idiopathic generalized epilepsy
- Author
-
Møller, R.S., Weber, Y.G., Klitten, L.L., Trucks, H., Muhle, H., Kunz, W.S., Mefford, H.C., Franke, A., Kautza, M., Wolf, P., Dennig, D., Schreiber, S., Rückert, I.M., Wichmann, H.E., Ernst, J.P., Schurmann, C., Grabe, H.J., Tommerup, N., Stephani, U., Lerche, H., Hjalgrim, H., Helbig, I., Sander, T., Zimprich, F., Mörzinger, M., Feucht, M., Suls, A., Weckhuysen, S., Claes, L., Deprez, L., Smets, K., Van Dyck, T., Deconinck, T., De Jonghe, P., Velizarova, R., Dimova, P., Radionova, M., Tournev, I., Kancheva, D., Kaneva, R., Jordanova, A., Kjelgaard, D.B., Lehesjoki, A.E., Siren, A., Baulac, S., Leguern, E., Von Spiczak, S., Ostertag, P., Leber, M., Leu, C., Toliat, M.R., Nürnberg, P., Hempelmann, A., Rüschendorf, F., Elger, C.E., Kleefuß Lie, A.A., Surges, R., Gaus, V., Janz, D., Schmitz, B., Klein, K.M., Reif, P.S., Oertel, W.H., Hamer, H.M., Rosenow, F., Becker, F., Marini, C., Guerrini, R., Mei, D., Norci, V., Zara, F., Striano, P., Robbiano, A., Pezzella, M., Bianchi, A., Gambardella, A., Tinuper, P., La Neve, A., Capovilla, G., Vigliano, P., Crichiutti, G., Vanadia, F., Vignoli, A., Coppola, A., Striano, S., Giallonardo, M.T., Franceschetti, S., Belcastro, V., Benna, P., Coppola, G., De Palo, A., Ferlazzo, E., Vecchi, M., Martinelli, V., Bisulli, F., Beccaria, F., Del Giudice, E., Mancardi, M., Stranci, G., Scabar, A., Gobbi, G., Giordano, I., Koeleman, B.P.C., De Kovel, C., Lindhout, D., De Haan, G.J., Ozbeck, U., Bebek, N., Baykan, B., Ozdemir, O., Ugur, S., Kocasoy Orhan, E., Yücesan, E., Cine, N., Gokyigit, A., Gurses, C., Gul, G., Yapici, Z., Ozkara, C., Caglayan, H., Yalcin, O., Yalcin, D., Turkdogan, D., Dizdarer, G., Agan, K., R. S. Møller, Y. G. Weber, L. L. Klitten, H. Truck, H. Muhle, W. S. Kunz, H. C. Mefford, A. Franke, M. Kautza, P. Wolf, D. Dennig, S. Schreiber, I. Rückert, H. Wichmann, J. P. Ernst, C. Schurmann, H. J. Grabe, N. Tommerup, U. Stephani, H. Lerche, H. Hjalgrim, I. Helbig, T. Sander, P. Tinuper, F. Bisulli, EPICURE Consortium, Suls, Arvid, Weckhuysen, Sarah, Claes, Godelieve, Deprez, Liesbet, Smets, Katrien, Van Dyck, Tine, Deconinck, Tine, De Jonghe, Peter, Jordanova, Albena, Møller, R, Weber, Yg, Klitten, Ll, Trucks, H, Muhle, H, Kunz, W, Mefford, Hc, Franke, A, Kautza, M, Wolf, P, Dennig, D, Schreiber, S, Rückert, Im, Wichmann, He, Ernst, Jp, Schurmann, C, Grabe, Hj, Tommerup, N, Stephani, U, Lerche, H, Hjalgrim, H, Helbig, I, Sander, T, Epicure, Consortium, DEL GIUDICE, Ennio, Coppola, Antonietta, and YÜCESAN, EMRAH
- Subjects
Male ,Idiopathic generalized epilepsy ,Neuronal ,Idiopathic Generalized Epilepsy ,1q21 ,1 Microdeletion ,Two-hit Hypothesis ,Nrxn1 ,Neuropsychological Tests ,Immunoglobulin E ,Cell Adhesion Molecules, Neuronal/genetics ,Adult, Age of Onset, Anticonvulsant ,Exon ,1q21.1 microdeletion ,Exons/genetics ,Odds Ratio ,Nerve Tissue Proteins/genetics ,Copy-number variation ,Valproic Acid/therapeutic use ,Age of Onset ,Neural Cell Adhesion Molecules ,genetics, DNA Copy Number Variations, Electroencephalography, Epilepsy ,Genetics ,biology ,Triazines ,Anticonvulsants/therapeutic use ,Electroencephalography ,genetics, Family, Female, Fructose ,Exons ,Middle Aged ,Settore MED/39 - Neuropsichiatria Infantile ,Pedigree ,therapeutic use, Valproic Acid ,Neurology ,Settore MED/26 - Neurologia ,Anticonvulsants ,Epilepsy, Generalized ,Female ,Adult ,Case-Control Studies ,Cell Adhesion Molecules, Neuronal ,DNA Copy Number Variations ,Family ,Fructose ,Gene Deletion ,Genotype ,Humans ,Infant ,Microarray Analysis ,Nerve Tissue Proteins ,Valproic Acid ,analogs /&/ derivatives/therapeutic use, Gene Deletion, Genotype, Humans, Infant, Male, Microarray Analysis, Middle Aged, Nerve Tissue Protein ,therapeutic use, Case-Control Studies, Cell Adhesion Molecule ,drug therapy/genetics/psychology, Exon ,genetics, Neuropsychological Tests, Odds Ratio, Pedigree, Triazine ,Lamotrigine ,NRXN1 ,Topiramate ,Epilepsy, Generalized/drug therapy ,medicine ,Allele ,Biology ,Gene ,Generalized ,Point mutation ,Calcium-Binding Proteins ,Odds ratio ,medicine.disease ,Triazines/therapeutic use ,Settore MED/03 - Genetica Medica ,therapeutic use ,biology.protein ,Fructose/analogs & derivatives ,Human medicine ,Neurology (clinical) ,Two-hit hypothesis - Abstract
Summary Purpose Neurexins are neuronal adhesion molecules located in the presynaptic terminal, where they interact with postsynaptic neuroligins to form a transsynaptic complex required for efficient neurotransmission in the brain. Recently, deletions and point mutations of the neurexin 1 (NRXN1) gene have been associated with a broad spectrum of neuropsychiatric disorders. This study aimed to investigate if NRXN1 deletions also increase the risk of idiopathic generalized epilepsies (IGEs). Methods We screened for deletions involving the NRXN1 gene in 1,569 patients with IGE and 6,201 controls using high-density oligonucleotide microarrays. Key Findings We identified exon-disrupting deletions of NRXN1 in 5 of 1,569 patients with IGE and 2 of 6,201 control individuals (p = 0.0049; odds ratio (OR) 9.91, 95% confidence interval (CI) 1.92–51.12). A complex familial segregation pattern in the IGE families was observed, suggesting that heterozygous NRXN1 deletions are susceptibility variants. Intriguingly, we identified a second large copy number variant in three of five index patients, supporting an involvement of heterogeneous susceptibility alleles in the etiology of IGE. Significance We conclude that exon-disrupting deletions of NRXN1 represent a genetic risk factor in the genetically complex predisposition of common IGE syndromes.
- Published
- 2013